Reproducibility of macular thickness measurement among five OCT instruments: Effects of image resolution, image registration, and eye tracking

Ophthalmic Surgery Lasers and Imaging

Volumn 43, Issue 2, 2012, Pages 97-108

  Chin, Eric K ^a   Sedeek, Ragui W ^a   Li, Yueju ^b   Beckett, Laurel ^b   Redenbo, Ellen ^a   Chandra, Karishma ^a   Park, Susanna S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; EYE TRACKING; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REPRODUCIBILITY; RETINA MACULOPATHY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; FEMALE; HUMANS; MACULA LUTEA; MACULAR DEGENERATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, OPTICAL COHERENCE; YOUNG ADULT;

EID: 84859834440     PISSN: 15428877     EISSN: None     Source Type: Journal    
DOI: 10.3928/15428877-20111222-02     Document Type: Article

References (44)

1. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254:1178-1181. (Pubitemid 21917444)
2. De Boer JF, Cense B, Park BH, Pearce MC, Tearney GJ, Bourna BE. Improved signal-to-noise ratio in spectral-domain compared with time-domain optical coherence tomography. Opt Lett. 2003;28:2067-2069.
3. Leitgeb R, Hitzenberger CK, Fercher AF. Performance of Fourier domain vs. time domain optically coherence tomography. Opt Express. 2003;11:889-894.
4. Choma M, Sarunic M, Yang C, Izatt J. Sensitivity advantage of swept source and Fourier domain optical coherence tomography. Opt Express. 2003;11:2183-2189.
5. Wojtkowski M, Bajraszewski T, Gorczynska I, et al. Ophthalmic imaging by spectral optical coherence tomography. Am J Ophthalmol. 2004;138:412-419. (Pubitemid 39208568)
6. Alam S, Zawadzki RJ, Choi S, et al. Clinical applications of serial Fourier-domain optical coherence tomography for macular imaging. Ophthalmology. 2006;113:1425-1431. (Pubitemid 44108165)
7. Gupta V, Gupta P, Singh R, Dogra MR, Gupta A. Spectral-domain Cirrus high-definition optical coherence tomography is better than time-domain Stratus optical coherence tomography for evaluation of macular pathologic features in uveitis. Am J Ophthalmol. 2008;145:1018-1022.
8. Sakamoto A, Hangai M, Yoshimura N. Spectral-domain optical coherence tomography with multiple B-scan averaging for enhanced imaging of retinal diseases. Ophthalmology. 2008;115:1071-1078.
9. Modjtahedi S, Chiou C, Modjtahedi B, Telander DG, Morse LS, Park SS. Comparison of macular thickness measurement and segmentation error rate between time-domain and fourier-domain optical coherence tomography. Ophthalmic Surg Laser Imaging. 2010;41:301-310.
10. Ho J, Sull AC, Vuong LN, et al. Assessment of artifacts and reproducibility across spectral- and time-domain optical coherence tomography devices. Ophthalmology. 2009;116:1960-1970.
11. Leung CK, Cheung CY, Weinreb RN, et al. Comparison of macular thickness measurements between time domain and spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2008;49:4893-4897.
12. Gonzalez-Garcia AO, Vizzeri G, Bowd C, Medeiros FA, Zangwill LM, Weinreb RN. Reproducibility of RTVue retinal nerve fiber layer thickness and optic disc measurements and agreement with Stratus optical coherence tomography measurements. Am J Ophthalmol. 2009;147:1067-1074.
13. Wolf-Schnurrbusch UEK, Ceklic L, Brinkmann CK, et al. Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments. Invest Ophthalmol Vis Sci. 2009;50:3432-3437.
14. Forooghian F, Cukras C, Meyerle CB, Chew EY, Wong WT. Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema. Invest Ophthalmol Vis Sci. 2008;49:4290-4296.
15. Krebs I, Haas P, Zeiler F, Binder S. Optical coherence tomography: limits of the retinal mapping program in age-related macular degeneration. Br J Ophthalmol. 2008;92:933-935. (Pubitemid 351969673)
16. Sadda SR, Wu Z, Walsh AC, et al. Errors in retinal thickness measurements obtained by optical coherence tomography. Ophthalmology. 2006;113:285-293. (Pubitemid 43170778)
17. Puliafito CA, Hee MR, Lin CP, et al. Imaging of macular diseases with optical coherence tomography. Ophthalmology. 1995;102:217-229.
18. Schaudig UH, Glaefke C, Scholz F, Richard G. Optical coherence tomography for retinal thickness measurement in diabetic patients without clinically significant macular edema. Ophthalmic Surg Lasers. 2000;31:182-186. (Pubitemid 30396772)
19. Hee MR, Puliafito CA, Wong C, et al. Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol. 1995;113:1019-1029.
20. Sanchez-Tocino H, Alvarez-Vidal A, Maldonado MJ, Moreno- Montañés J, García-Layana A. Retinal thickness study with optical coherence tomography in patients with diabetes. Invest Ophthalmol Vis Sci. 2002;43:1588-1594. (Pubitemid 34462662)
21. Coscas G, Coascas F, Vismara S, Souied E, Soubrane G. Spectral domain OCT in age-related macular degeneration: preliminary results with Spectralis HRA-OCT [article in French]. J Fr Ophtalmol. 2008;31:353-361.
22. Fung AE, Lalwani GA, Rosenfeld PJ, et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol. 2007;143:566-583.
23. Fleckenstein M, Charbel Issa P, Helb HM, et al. High-resolution spectral-domain OCT imaging in geographic atrophy associated with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008;49:4137-4144.
24. Yamaike N, Tsjikawa A, Ota M, et al. Three-dimensional imaging of cystoid macular edema in retinal vein occlusion. Ophthalmology. 2008;115:355-362.
25. Nussenblatt RB, Kaufman SC, Palestine AG, Davis MD, Ferris FL 3rd. Macular thickening and visual acuity: measurements in patients with cystoid macular edema. Ophthalmology. 1987;94:1134-1139. (Pubitemid 17151684)
26. Meredith TA, Kenyon KR, Singerman LJ, Fine SL. Perifoveal vascular leakage and macular oedema after intracapsular cataract extraction. Br J Ophthalmol. 1976;60:765-769. (Pubitemid 8005652)
27. Stark WJ Jr, Maumenee AE, Fagadau W, et al. Cystoid macular edema is pseudophakia. Surv Ophthalmol. 1984;28(suppl):442-451.
28. Lam DS, Chan CK, Mohamed S, et al. Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes. Ophthalmology. 2007;114:2162-2167.
29. Chew E, Strauber S, Beck R, et al. Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: a pilot study. Ophthalmology. 2007;114:1190-1196.
30. Patel PJ, Chen FK, Ikeji F, et al. Repeatability of stratus optical coherence tomography measures in neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008;49:1084-1088.
31. Campbell RJ, Coupland SG, Buhrmann RR, Kertes PJ. Effect of eccentric and inconsistent fixation on retinal optical coherence tomography measures. Arch Ophthalmol. 2007;125:624-627. (Pubitemid 46762722)
32. Chan A, Duker JS, Ko TH, Fujimoto JG, Schuman JS. Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography. Arch Ophthalmol. 2006;124:193-198. (Pubitemid 43247068)
33. Brennen PM, Kagemann L, Friberg TR. Comparison of Stratus OCT and Cirrus HD-OCT imaging in macular diseases. Ophthalmic Surg Laser Imaging. 2009;40:25-31.
34. Geitzenauer W, Kiss CG, Durbin MK, et al. Comparing retinal thickness measurements from Cirrus spectral domain- and Stratus time domain-optical coherence tomography. Retina. 2010;30:596-606.
35. Forte R, Cennamo GL, Finelli ML, de Crecchio G. Comparison of time domain Stratus OCT and spectral domain SLO/OCT for assessment of macular thickness and volume. Eye. 2009;23:2071-2078.
36. Kakinoki M, Sawada O, Sawada T, Kawamura H, Ohji M. Comparison of macular thickness between Cirrus HD-OCT and Stratus OCT. Ophthalmic Surg Lasers Imaging. 2009;40:135-140.
37. Legarreta JE, Gregori G, Punjabi OS, Knighton RW, Lalwani GA, Puliafito CP. Macular thickness measurements in normal eyes using spectral domain optical coherence tomography. Ophthalmic Surg Laser Imaging. 2008;39(suppl):S43-S49.
38. Kiernan DF, Hariprasad SM, Chin EK, Kiernan CL, Rago J, Mieler WF. Prospective comparison of Cirrus and Stratus optical coherence tomography for quantifying retinal thickness. Am J Ophthalmol. 2009;147:267-275.
39. Moller F, Bek T. The relation between visual acuity, fixation stability, and the size and location of foveal hard exudates after photocoagulation for diabetic maculopathy: a 1-year follow-up study. Graefes Arch Clin Exp Ophthalmol. 2003;241:458-462. (Pubitemid 36833741)
40. Moller F, Sjolie AK, Bek T. Quantitative assessment of fixational eye movements by scanning laser ophthalmoscopy. Acta Ophthalmol Scand. 1996;74:578-583. (Pubitemid 27042682)
41. Kiernan DF, Mieler WF, Hariprasad SM. Spectral-domain optical coherence tomography: a comparison of modern high-resolution retinal imaging systems. Am J Ophthalmol. 2010;149:18-31.
42. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310. (Pubitemid 16134762)
43. Grover S, Murthy RK, Brar VS, Chalam KV. Normative data for macular thickness by high-definition spectral-domain optical coherence tomography (Spectralis). Am J Ophthalmol. 2009;148:266-271.
44. Menke MN, Dabov S, Knecht P, Sturm V. Reproducibility of retinal thickness measurements in healthy subjects using Spectralis optical coherence tomography. Am J Ophthalmol. 2009;147:467-472.